Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Wednesday, 12 July 2017

Sanofi: Availability of the Pre-quarterly Results Communication

Sanofi    

Published: 22:30 CEST 12-07-2017 /GlobeNewswire /Source: Sanofi / : SAN /ISIN: FR0000120578


Availability of the Pre-quarterly Results Communication

 

Paris, France - July 12, 2017 - Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors" page of the company's corporate website:

http://en.sanofi.com/investors/events/Results/2017-07-31_Results_Q2_2017.aspx

 

As for each quarter, Sanofi prepared this document to assist in the financial modeling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well as the foreign currency impact and share count.  Sanofi's second quarter results will be published on July 31, 2017.

 

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

 

 

Contacts:

 

Media Relations
Laurence Bollack
Tel. : +33 (0)1 53 77 46 46
mr@sanofi.com

Investor Relations
George Grofik
Tel.: +33 (0)1 53 77 45 45
ir@sanofi.com

 



Press release (PDF)



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of NASDAQ OMX Corporate Solutions clients. Source: Sanofi, 54 rue la Boetie, PARIS 75008, FRANCE
If you would like to unsubscribe and stop receiving these e-mails click here.